Biosynthesis of mycobacterial arabinogalactan: identification of a novel α(1→3) arabinofuranosyltransferase
2008

Discovery of a New Enzyme in Mycobacterial Cell Wall Biosynthesis

publication 10 minutes Evidence: high

Author Information

Author(s): Helen L Birch, Luke J Alderwick, Apoorva Bhatt, Doris Rittmann, Karin Krumbach, Albel Singh, Yu Bai, Todd L Lowary, Lothar Eggeling, Gurdyal S Besra

Primary Institution: School of Biosciences, University of Birmingham

Hypothesis

The study aims to identify new arabinofuranosyltransferases involved in the biosynthesis of mycobacterial arabinogalactan.

Conclusion

The newly identified enzyme AftC is crucial for the synthesis of α(1→3)-linked arabinofuranosyl residues in mycobacterial arabinogalactan.

Supporting Evidence

  • Deletion of MSMEG2785 in Mycobacterium smegmatis resulted in altered growth and absence of α(1→3)-linked arabinofuranosyl residues.
  • Complementation of the deletion mutant restored the wild-type phenotype.
  • AftC was identified as a novel enzyme responsible for the transfer of Araf residues.

Takeaway

Scientists found a new enzyme that helps build a part of the bacteria's protective wall, which could help in creating new medicines against tuberculosis.

Methodology

The study involved genetic deletion of the MSMEG2785 gene in Mycobacterium smegmatis and subsequent analysis of growth and cell wall composition.

Limitations

The study primarily focuses on laboratory strains and may not fully represent the complexities of mycobacterial infections in humans.

Digital Object Identifier (DOI)

10.1111/j.1365-2958.2008.06354.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication